AngioDynamics Inc. (ANGO) Tops Q3 EPS by 3c, Provides FY11 Guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.44 +0.46%
Revenue Growth %: +6.3%
Financial Fact:
Amortization of intangibles: 4.24M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +6.3%
Financial Fact:
Amortization of intangibles: 4.24M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
AngioDynamics Inc. (NASDAQ: ANGO) reported Q3 EPS of $0.15, $0.03 better than the analyst estimate of $0.12. Revenue for the quarter came in at $54.6 million versus the consensus estimate of $53.89 million.
AngioDynamics Inc. sees FY2011 EPS of $0.48-$0.50, versus the consensus of $0.49. AngioDynamics Inc. sees FY2011 revenue of $217-$220 million, versus the consensus of $220.2 million.
AngioDynamics Inc. sees FY2011 EPS of $0.48-$0.50, versus the consensus of $0.49. AngioDynamics Inc. sees FY2011 revenue of $217-$220 million, versus the consensus of $220.2 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- LuxExperience B.V. (LUXE) Misses Q2 EPS by 11c
- Fluence Energy cuts fiscal 2026 revenue outlook on supply chain woes
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
